2021 WHO CNS classifies HGGs into IDH-wildtype glioblastoma, IDH-mutant astrocytoma, and IDH-mutant, 1p/19q-codeleted oligodendroglioma, enabling molecularly driven prognostication. This evidence concerns the gene IDH1 and oligodendroglioma.